Login to Your Account



Chinese biopharmas eager to translate 'innovation' into drug approvals

By Marie Powers
Staff Writer

Wednesday, May 14, 2014

SUZHOU, China ­– "Innovation" is a prominent theme in China's life sciences community, but for all the talk about the need to move from generics to novel drugs, focusing on the science without generating results is a wasted effort. That, in short, is a key message emerging from Chinese life science executives and research leaders at the Chinabio Partnering Forum.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription